Menu

Enovis Corporation ENOV

Full chart Compare
Set alert

Price alert · ENOV

All alert types
28.49 USD +0.27 (+0.94%)

Nov 11, 2026, 12:22 PM EST

27.74 Day range 28.92
16.70 52-week range 32.41
YTD
+6.93%
1 year
-9.60%
Market cap
1.64B
Revenue (ttm)
2.31B
Profit margin
-22.87%
EPS (ttm)
-9.23
Shares out
57.69M
Forward P/E
8.05
YTD return
+6.93%
1-year return
-9.60%
Volume
263.56K
Avg volume
1.68M
Open
28.01
Previous close
28.22
Day's range
27.74 – 28.92
52-week range
16.70 – 32.41
Beta
1.42
Analysts
Strong Buy
Price target
37.83 (+32.8%)
Earnings date
Feb 25, 2027

5D +4.88 (+20.91%)

242628WedThuFriMonTue28.22

Key statistics

Enterprise value
2.98B
PEG ratio
3.45
Price / sales
0.71
Price / book
1.09
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
1.80%
Free cash flow
151.48M
Total cash
13.04M
Total debt
1.34B
Return on equity
-29.95%
Short % of float
24.17%
50-day average
19.97
200-day average
23.12

Financials — quick view

All financials
ENOV Revenue — quarterly 558.73M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
ENOV Net income — quarterly 3.14M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
ENOV EPS — quarterly 0.06
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

ENOV recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 25, 2027Jan 2, 20271.07———
Nov 5, 2026Oct 2, 20260.7670.88+0.11+14.73%
Aug 6, 2026Jul 3, 20260.8470.90+0.05+6.26%
May 7, 2026Apr 3, 20260.820.89+0.07+8.54%
Feb 26, 2026Dec 31, 20250.810.95+0.14+17.28%
Nov 6, 2025Oct 3, 20250.670.75+0.08+11.94%

Upgrades / downgrades

ENOV analyst upgrades and downgrades
DateFirmActionFromTo
Nov 6, 2026Canaccord GenuitymainBuyBuy
Nov 6, 2026Evercore ISI GroupmainOutperformOutperform
Nov 6, 2026Wells FargomainOverweightOverweight
Nov 5, 2026NeedhammainBuyBuy
Nov 5, 2026BTIGmainBuyBuy
Oct 12, 2026NeedhammainBuyBuy

About Enovis Corporation

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Lewisville, Texas.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
enovis.com

News

Your note

Sign in to keep a note on ENOV — it syncs with the Stock Master app.

Insider holders

ENOV insider holders
InsiderRelationLatest transactionDateShares held
BERRY PHILLIP BENJAMIN BENChief Financial OfficerStock Award(Grant)Mar 8, 2026158,596
ENGERT OLIVEROfficerPurchaseSep 3, 202663,898
LANG PATRICIA AOfficerStock Award(Grant)Mar 8, 202675,703
MCDONALD DAMIENChief Executive OfficerPurchaseSep 3, 2026247,077
PRYOR DANIEL ALEXISFormerSaleDec 8, 20250
ROSS TERRY DOfficerStock Award(Grant)Mar 8, 202668,477

Institution ownership

ENOV institution ownership
Holder% heldSharesValueReported
Blackrock Inc.17.85%10,295,666290.49MJun 29, 2026
American Century Companies Inc10.58%6,106,561172.30MJun 29, 2026
Vanguard Portfolio Management LLC6.81%3,926,268110.78MJun 29, 2026
Rubric Capital Management LP6.76%3,900,000110.04MJun 29, 2026
Vanguard Capital Management LLC4.31%2,484,31870.10MJun 29, 2026
State Street Corporation4.27%2,462,78869.49MJun 29, 2026

Fund ownership

ENOV fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.95%3,431,56996.82MSep 29, 2026
American Century Capital Portfolios, Inc.-Small Cap Value Fund3.88%2,240,00063.20MSep 29, 2026
American Century ETF Trust-Avantis U.S. Small Cap Value ETF3.79%2,189,18261.77MSep 29, 2026
Fidelity Securities Fund-Fidelity Small Cap Value Fund3.52%2,032,40657.34MAug 30, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.98%1,719,53048.52MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.59%1,493,64342.14MSep 29, 2026